BAYESIAN PHARMACOKINETIC PHARMACODYNAMIC FORECASTING OF PROTHROMBIN RESPONSE TO WARFARIN THERAPY - PRELIMINARY EVALUATION

被引：37

作者：

SVEC, JM

COLEMAN, RW

MUNGALL, DR

LUDDEN, TM

机构：

[1] BIOTRACK CORP,1234 ELKO DR,SUNNYVALE,CA 94086

[2] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712

[3] VET ADM MED CTR,PHARM SERV,PALO ALTO,CA 94304

来源：

THERAPEUTIC DRUG MONITORING | 1985年 / 7卷 / 02期

关键词：

D O I：

10.1097/00007691-198506000-00006

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：174 / 180

页数：7

共 21 条

[1]

COON WW, 1970, CLIN PHARMACOL THER, V11, P312

[2]

KELLY JG, 1979, CLIN PHARMACOKINET, V4, P1, DOI 10.2165/00003088-197904010-00001

[3]

KELMAN AW, 1982, COMPUT PROG BIOMED, V14, P239, DOI 10.1016/0010-468X(82)90029-0

[4]

MCGHEE JR, 1981, J AM OSTEOPATH ASSOC, V80, P335

[5] PREDICTING WARFARIN MAINTENANCE DOSAGE BASED ON INITIAL RESPONSE [J].

MILLER, DR ;

BROWN, MA .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (10) :1351-1355

[6]

MUNGALL DR, 1983, 2ND WORLD C CLIN PHA

[7]

NAGASHIMA R, 1969, CLIN PHARMACOL THER, V10, P22

[8] STUDIES ON COUMARIN ANTICOAGULANT DRUGS - INITIATION OF WARFARIN THERAPY WITHOUT A LOADING DOSE [J].

OREILLY, RA ;

AGGELER, PM .

CIRCULATION, 1968, 38 (01) :169-&

[9]

OREILLY RA, 1970, PHARMACOL REV, V22, P33

[10]

PECK CC, 1980, 4TH P ANN C COMP MED, V2, P988

← 1 2 3 →